Please assess the completion status of the following clinical trial:

Trial Title: Metabolic Modulation as Treatment in Acute Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Acute heart failure~* NYHA class III - IV.~* ejection fraction \<35~Exclusion Criteria:~* Age \<18 år or \>85 år,~* allergy~* renal failure~* recently developed brady- or tachy-arrythmias~* Serious infection~* Heart failure due to restrictive or hypertrophic cardiomyopathy or stenotic valvular heart disease~* Recent Myocardial infarction (\<6 Weeks)~* Pulmonary Wedge pressure \>30 mm Hg~* diabetes mellitus treated with insulin~* peptic ulcer~* pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).